Board Member of READDI. A public-private partnership to develop 5 novel broad spectrum anti-virals for the next pandemic. Acting as interim Executive Director and President.

Founded a family foundation to support the educational needs of disadvantaged youth in the Indianapolis and South Florida communities. Primary focus is scholarships in the Arts and Science.

Bioinspired Drug Development ..... Enabled by Chemistry

Founding board member of local non-profit charity. Secretary of the board that made the Indianapolis brand of the charity the most productive in the Country.

Total focus in this high-profile worldwide role includes planning, comprehensive review and global execution of all therapeutic area strategies. Selected highlights include building new brand teams focused on creating, refining and instituting critical global strategy work for launches. Highlights include:• Took over the refinement and strategic revision of immunology and pain TAs for Lilly. Cross functional effort required and continues to require extensive planning; current projected outcomes include a brand new 5-10 year Lilly Vision for each TA. T• Led the commercial assessment and worked with BD to acquire CoLucid for $960M. Brand will be the first new acute med to launch in migraine for 20 years. • Successfully developed, created and supervised the first two global launches in immunology for Lilly. Focused work in this area has required a combination of building high quality marketing teams, working seamlessly with the medical teams and development of great brand positioning oriented around a clear target patient for each drug. • Appointed to and currently serving as LLY Chair of joint steering committee in LLY/PFE Alliance on a monoclonal antibody for chronic pain.

Led a team of 250 marketers across Eli Lilly’s US business. Picked up a disengaged team and turned them into a high performing team of engaged marketers. Developed, managed, and oversaw business for LillyUSA. Highlights include:• Exceeded revenue targets all fours years in the affiliate.• Delivered digital marketing strategy for the affiliate; recognized for transforming operatIons as an enterprise around technology by powerfully partnering with IT and transforming web properties. Built a social capability and a central multi-channel marketing capability to communicate through digital channels to HCPs.• Turned around performance of two declining brands in 6 months. CNS brand had been in decline for 7 years. Recreated the entire leadership team for each brand, revising and simplifying the strategy; clearly identified the target patient for each brand and aligned entire enterprise to the new strategy. • Integral team member on program that delivered the single largest restructure in affiliate’s history.

Gained ED market leadership with WW with core ED brand (Revenue >$2Bn). Was able to align the majority of affiliates to our global strategy, gain significant investments in lifecycle and commercial spend to drive success and hired top alent around the world to support the brand. Highlights include:• Licensed PAH brand to UT in the US – identified PAH/orphan disease not core competency. Thoroughly developed competitive process to successfully identify partner. • Licensed novel under arm testosterone. – in building out urology business identified a novel application of TRT for the same target doctors from a small biotech in Melbourne, Australia. Again, built a strong, long-term partnership.• Acquisition of ED Biotech for $2.1B. Having successfully launched ED brand we determined acquisition was the best strategy for the long-term. As part of the deal team worked closely with the partner's CEO & CFO to agree on the terms of the deal which is still considered one of the best BD deals ever completed at Lilly.

Provided international leadership, focus, operations and strategy for maximizing revenue growth and market share for ED Brand worldwide. Highlights include:• Highly successfully launched ED Brand WW and delivered above expectations for 5 consecutive years.• Team awarded Marketing Team of the Year on three occasions (2 internally, one externally).http://www.stevieawards.com/pubs/awards/70_1871_11715.cfm

Provided international leadership, focus, operations and strategy for maximizing revenue growth and market share for Key CNS brand worldwide. Highlights include:• Delivered review of brand strategy and development of first Global Marketing campaign.• Awarded MVP award on team in 2002.

• Returned key CNS brand to growth in the UK within six months of appointment in 2000. Brand was in decline after 2 years in market, identified strategy, focus and alignment issues with the leadership team. Personally led the fix of these elements that directly led to turn performance positive in the next six months. • Launched first two insulin pen devices in the UK during a period of unprecedented growth for Lilly Diabetes UK.• Named Sales Representative of the Year 1991. In two years took territory to #1 in the country.

Was an active Board member at the school for six years. Worked to successfully address enrolment shortfall through the development of a marketing plan for the school and establishing a scholarship program with the Center for Leadership Development.